HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Patricia V Elizalde Selected Research
Patricia V Elizalde Research Topics
Disease
33
Breast Neoplasms (Breast Cancer)
12/2023 - 08/2002
29
Neoplasms (Cancer)
10/2023 - 08/2002
10
Carcinogenesis
05/2015 - 02/2003
6
Neoplasm Metastasis (Metastasis)
01/2020 - 08/2002
5
Triple Negative Breast Neoplasms
12/2023 - 01/2020
5
Adenocarcinoma
06/2005 - 02/2003
1
Genomic Instability
07/2021
1
Oncogene Addiction
01/2020
1
Melanoma (Melanoma, Malignant)
01/2020
1
Carcinoma (Carcinomatosis)
12/2017
1
Infections
01/2017
1
Leukemia
05/2012
1
Hypersensitivity (Allergy)
01/2012
Drug/Important Bio-Agent (IBA)
19
Progesterone Receptors (Progesterone Receptor)
IBA
12/2023 - 02/2003
11
Progestins (Progestagens)
IBA
05/2015 - 02/2003
6
STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
IBA
12/2023 - 06/2005
6
Estrogens (Estrogen)
FDA Link
01/2022 - 06/2007
6
Progesterone
FDA Link
Generic
05/2015 - 02/2003
5
Hormones (Hormone)
IBA
10/2020 - 03/2009
5
Mitogen-Activated Protein Kinase 3
IBA
01/2017 - 01/2004
5
Neuregulin-1 (Neuregulin 1)
IBA
10/2015 - 08/2002
5
Medroxyprogesterone Acetate (Depo-Provera)
FDA Link
Generic
05/2015 - 02/2003
4
Protein Isoforms (Isoforms)
IBA
12/2023 - 02/2003
4
Somatomedin Receptors (Somatomedin Receptor)
IBA
10/2023 - 01/2004
4
Trastuzumab (Herceptin)
FDA Link
01/2023 - 07/2010
4
Messenger RNA (mRNA)
IBA
07/2021 - 01/2004
4
Biomarkers (Surrogate Marker)
IBA
10/2020 - 02/2012
4
Cytokines
IBA
01/2020 - 07/2010
4
Phosphotransferases (Kinase)
IBA
01/2019 - 03/2009
4
tyrosine receptor (receptor, tyrosine)
IBA
01/2019 - 03/2009
4
histidine-rich proteins
IBA
05/2012 - 08/2002
3
Steroids
IBA
12/2023 - 03/2009
3
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2022 - 08/2002
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2020 - 02/2008
3
Peptide Hydrolases (Proteases)
FDA Link
06/2007 - 08/2002
3
Oligodeoxyribonucleotides
IBA
03/2006 - 01/2004
3
Progesterone Congeners
IBA
06/2005 - 02/2003
2
Transcription Factor AP-1 (Transcription Factor AP 1)
IBA
11/2023 - 12/2013
2
RNA (Ribonucleic Acid)
IBA
07/2021 - 05/2012
2
Phenobarbital (Luminal)
FDA Link
10/2020 - 01/2020
2
Tamoxifen
FDA Link
Generic
01/2018 - 12/2013
2
Ligands
IBA
01/2018 - 05/2012
2
Estrogen Receptors
IBA
12/2017 - 12/2013
2
Proteins (Proteins, Gene)
FDA Link
12/2014 - 02/2003
2
NF-kappa B (NF-kB)
IBA
07/2010 - 02/2008
2
Mitogen-Activated Protein Kinases
IBA
07/2004 - 02/2003
2
Tyrosine (L-Tyrosine)
FDA Link
07/2004 - 01/2004
2
Insulin Receptor Substrate Proteins
IBA
07/2004 - 01/2004
1
6-methyladenine
IBA
07/2021
1
Methyltransferases
IBA
07/2021
1
Immune Checkpoint Inhibitors
IBA
01/2020
1
Estrogen Receptor Modulators (Antiestrogen)
IBA
01/2018
1
Transcription Factors (Transcription Factor)
IBA
01/2018
1
Glycoproteins (Glycoprotein)
IBA
12/2017
1
human ERBB2 protein
IBA
12/2017
1
Mucin-4
IBA
02/2017
1
Blocking Antibodies
IBA
02/2017
1
Mucins
IBA
02/2017
1
Finasteride (Propecia)
FDA Link
Generic
05/2015
1
Cyclin A2
IBA
12/2014
1
Cyclin D1
IBA
12/2013
1
Cyclin-Dependent Kinase Inhibitor p21
IBA
06/2013
1
Chemokines
IBA
08/2012
1
MicroRNAs (MicroRNA)
IBA
05/2012
1
Cyclin E
IBA
05/2012
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
05/2012
1
Catalytic DNA (Deoxyribozyme)
IBA
04/2012
1
Insulin-Like Growth Factor I (IGF-1)
IBA
01/2012
1
Small Interfering RNA (siRNA)
IBA
01/2012
1
Nucleotides
IBA
01/2012
1
Monoclonal Antibodies
IBA
07/2010
1
Type II Tumor Necrosis Factor Receptors
IBA
02/2008
1
3- (4- methylphenylsulfonyl)- 2- propenenitrile
IBA
02/2008
1
Type I Tumor Necrosis Factor Receptors
IBA
02/2008
1
HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)
IBA
03/2006
1
Fas Ligand Protein (Fas Ligand)
IBA
03/2006
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
07/2004
1
Transforming Growth Factor beta (TGF-beta)
IBA
08/2003
1
Phosphatidylinositols (Phosphatidylinositol)
IBA
08/2002
1
Plasminogen Activators (Plasminogen Activator)
IBA
08/2002
1
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
08/2002
1
heregulin beta1
IBA
08/2002
Therapy/Procedure
6
Therapeutics
11/2023 - 12/2013
2
Immunotherapy
01/2020 - 08/2012
2
Drug Therapy (Chemotherapy)
01/2020 - 12/2017